Dino Amadori, MD

Articles by Dino Amadori, MD

Doxorubicin and Paclitaxel (Sequential Combination) in the Treatment

ByDino Amadori, MD,Giovanni Luca Frassineti, MD,Carlo Milandri, MD,Patrizia Serra, PhD,Amelia Tienghi, MD,Alberto Ravaioli, MD,Alfonso Gentile, MD,Ernesto Salzano, MD

April 1st 1997

Based on preclinical data, we designed a phase I/II clinical trial to determine the efficacy and toxicity of doxorubicin followed by paclitaxel in the treatment of advanced breast cancer (either untreated or relapsed after

Latest Updated Articles

Doxorubicin and Paclitaxel (Sequential Combination) in the Treatment
Published: April 1st 1997 | Updated:

Dino Amadori, MD

Articles by Dino Amadori, MD

Doxorubicin and Paclitaxel (Sequential Combination) in the Treatment

Latest Updated Articles

Trending on CancerNetwork

What is the Impact of the SHARON Trial on Pancreatic Cancer Research?

Pembrolizumab/Belzutifan Improves DFS in ccRCC Following Nephrectomy

Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group

Pelareorep Combo Yields Responses in Squamous Cell Anal Carcinoma

ZEN-3694 Earns FDA Orphan Drug Designation in NUT Carcinoma